Blair William & Co. IL Lowers Position in 1Life Healthcare, Inc. (NASDAQ:ONEM)

Blair William & Co. IL decreased its stake in 1Life Healthcare, Inc. (NASDAQ:ONEM) by 3.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 185,834 shares of the company’s stock after selling 6,675 shares during the quarter. Blair William & Co. IL owned approximately 0.14% of 1Life Healthcare worth $7,262,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of ONEM. HM Payson & Co. grew its stake in shares of 1Life Healthcare by 71.4% during the 4th quarter. HM Payson & Co. now owns 732 shares of the company’s stock valued at $32,000 after acquiring an additional 305 shares during the period. Valeo Financial Advisors LLC boosted its position in shares of 1Life Healthcare by 102.3% in the first quarter. Valeo Financial Advisors LLC now owns 866 shares of the company’s stock worth $34,000 after purchasing an additional 438 shares during the period. NN Investment Partners Holdings N.V. purchased a new stake in shares of 1Life Healthcare in the first quarter worth $94,000. Public Employees Retirement System of Ohio purchased a new position in shares of 1Life Healthcare during the 4th quarter valued at $167,000. Finally, Russell Investments Group Ltd. bought a new position in 1Life Healthcare in the 1st quarter worth $167,000. 83.93% of the stock is currently owned by hedge funds and other institutional investors.

In other news, General Counsel Lisa A. Mango sold 1,915 shares of the stock in a transaction on Monday, April 26th. The shares were sold at an average price of $42.15, for a total value of $80,717.25. Following the sale, the general counsel now owns 81,667 shares in the company, valued at $3,442,264.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Lisa A. Mango sold 3,004 shares of the firm’s stock in a transaction on Thursday, April 1st. The stock was sold at an average price of $42.04, for a total transaction of $126,288.16. Following the transaction, the general counsel now directly owns 81,769 shares of the company’s stock, valued at approximately $3,437,568.76. The disclosure for this sale can be found here. Insiders have sold a total of 84,187 shares of company stock worth $3,438,649 in the last 90 days.

Several analysts recently issued reports on the company. Evercore ISI initiated coverage on 1Life Healthcare in a research note on Monday, March 15th. They set an “outperform” rating and a $48.00 target price on the stock. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell reduced their price objective on shares of 1Life Healthcare from $61.00 to $55.00 and set a “buy” rating on the stock in a research report on Thursday, May 13th. Canaccord Genuity dropped their target price on shares of 1Life Healthcare from $64.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, May 13th. Morgan Stanley lifted their price target on shares of 1Life Healthcare from $44.00 to $50.00 and gave the company an “overweight” rating in a report on Monday, March 1st. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of 1Life Healthcare from $50.00 to $39.00 and set a “buy” rating for the company in a report on Wednesday, June 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and fourteen have issued a buy rating to the company’s stock. 1Life Healthcare currently has a consensus rating of “Buy” and a consensus price target of $47.47.

Shares of ONEM opened at $34.77 on Tuesday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 5.49 and a current ratio of 5.53. The stock has a fifty day moving average of $37.77. The company has a market capitalization of $4.78 billion, a P/E ratio of -48.29 and a beta of 1.30. 1Life Healthcare, Inc. has a 52-week low of $25.40 and a 52-week high of $59.82.

1Life Healthcare (NASDAQ:ONEM) last released its earnings results on Tuesday, May 11th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.14) by ($0.15). The firm had revenue of $121.40 million during the quarter, compared to the consensus estimate of $116.15 million. 1Life Healthcare had a negative return on equity of 18.06% and a negative net margin of 22.27%. 1Life Healthcare’s revenue was up 54.1% compared to the same quarter last year. During the same quarter last year, the business posted ($0.40) EPS. On average, sell-side analysts anticipate that 1Life Healthcare, Inc. will post -0.81 EPS for the current year.

1Life Healthcare Profile

1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs.

See Also: What impact do institutional investors have on markets?

Institutional Ownership by Quarter for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.